Sectors
CNTX
Context Therapeutics Inc.
0.39
2 x 0.27
2 x 0.49
bid
ask
+
0.01
1.56%
2 @ 06:03 PM
0.40 +0.01 (2.36%)
| Ytd | -73.49% | |
| 1y | -53.61% |
0.37
day range
0.40
0.37
52 week range
3.62
| Open | 0.39 | Prev Close | 0.38 | Low | 0.37 | High | 0.40 | Mkt Cap | 35.81M |
| Vol | 1.25M | Avg Vol | 2.85M | EPS | -0.48 | P/E | N/A | Forward P/E | -3.38 |
| Beta | 2.25 | Short Ratio | 2.79 | Inst. Own | 76.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 0.57 | 200-d Avg | 1.66 | 1yr Est | 7.70 |
| Income Statement | |||
| Operating Expenses | 14.98M | ||
| Research and Development Expense | 12.53M | ||
| Selling, General and Administrative Expense | 2.44M | ||
| Operating Income | -14.98M | ||
| Net Income | -14.56M | ||
| Net Income Common Stock | -14.56M | ||
| Net Income Common Stock (USD) | -14.56M | ||
| Consolidated Income | -14.56M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -14.56M | ||
| Earning Before Interest & Taxes (USD) | -14.56M | ||
| Weighted Average Shares | 95.18M | ||
| Weighted Average Shares Diluted | 95.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 42.99M | ||
| Cash and Equivalents (USD) | 42.99M | ||
| Current Assets | 45.82M | ||
| Property, Plant & Equipment Net | 315.29K | ||
| Total Assets | 46.13M | ||
| Debt Current | 167.47K | ||
| Total Debt | 244.99K | ||
| Current Liabilities | 7.88M | ||
| Debt Non-Current | 77.52K | ||
| Total Liabilities | 7.96M | ||
| Accumulated Retained Earnings (Deficit) | -154.14M | ||
| Shareholders Equity | 38.17M | ||
| Shareholders Equity (USD) | 38.17M | ||
| Assets Non-Current | 315.29K | ||
| Total Debt (USD) | 244.99K | ||
| Liabilities Non-Current | 77.52K | ||
| Trade and Non-Trade Payables | 3.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 45.47K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.54M | ||
| Capital Expenditure | -18.49K | ||
| Net Cash Flow from Investing | -4.52M | ||
| Net Cash Flow from Operations | -7.02M | ||
| Share Based Compensation | 528.10K | ||